The development of second primary tumors (SPTs) in patients with head and neck squamous cell carcinoma (HNSCC) has become an increasingly important factor in clinical treatment decison. Currently, clinical and histologic parameters are used to determine whether or not SPT is present. Recent studies suggest that many SPTs in the upper aerodigestive tract have a common clonal origin, challenging the longstanding multiclonal origin concept. To determine genetic relationships among multiple oral cancerous and precancerous lesions (MOCP), we analysed 100 lesions from 26 Japanese patients. Lesion development was synchronous and metachronous. We looked for patterns of microsatellite alterations (MA) using seven markers at chromosomes 3p14, 9p21, and 17p13, where MA occurs early in oral carcinogenesis. Loss of heterozygosity (LOH) was found in 52.6% (41/78), 62.5% (60/96), and 59.3% (32/54) of informative MOCP at 3p14, 9p21, and 17p13, respectively. Microsatellite instability (MI) was observed in 11, 26 and 13% of the samples at 3p14, 9p21, and 17p13 markers, respectively. Patterns of MA were concordant in only nine (14%) of 63 lesions from four (18%) of 22 patients who initially presented with noninvasive lesions. However, two of four patients with invasive cancer as indexed lesion showed 16 (43%) clonally related MOCP among 37 lesions (P=0.003). The results suggest that the majority of MOCP arise from clonally independent cells aected by ®eld cancerization. However, the probability of mucosal spread of clonal malignant or premalignant cells may increase along with malignant progression. Oncogene (2001) 20, 2235 ± 2242.
Introduction

HNSCC
3 is a common tumor type worldwide with 50 000 new cases each year in the United States alone (Vokes et al., 1993) . Clinicians have long known that multiple tumors can develop synchronously or metachronously in the upper aerodigestive tract. On the basis of clinicopathological observations of oral squamous cell carcinomas, in 1953, Slaughter et al. (1953) proposed the concept of ®eld cancerization to explain the development of SPTs. The hypothesis was supported by subsequent clinical and molecular studies (Chung et al. 1993; Buller et al., 1998; Sozzi et al., 1995) . The SPTs in patients with HNSCC have become an important clinical issue because of the increasing incidence of SPTs in head and neck cancer and the negative impact of such tumors on long-term survival of patients (Vokes et al., 1993; Jones et al., 1995; Schwartz et al., 1994) . It is important to learn more about the molecular mechanisms of developing of SPTs to establish new strategies to treat patients with HNSCC and to prevent SPT development.
The diagnosis of SPTs is currently based on clinical and histological parameters. However, independent origins of some clinically determined SPTs have recently been challenged. By using X chromosome inactivation analysis, Sidransky et al. (1992) reported evidence to support a common clonal origin of multiple bladder tumors. Subsequent cytogenetic and genetic analysis suggest that SPTs in the head and neck could also be clonally related and that these multiple lesions are a result of clonal spreading rather than independent tumors (Worsham et al., 1995; Bedi et al., 1996) . Other recent reports, however, provide evidence to support SPT development in two dierent pathways, i.e., independently in a ®eld of defects or via clonal spreading of transformed cells from the primary index tumors (Scholes et al., 1998; Lydiatt et al., 1998) .
The development of HNSCC is a multistep process involving the accumulation of genetic and epigenetic alterations in key regulatory genes (Bishop, 1987; Califano et al., 1997) . Deletion of somatic DNA at several tumor suppressor loci occurs early in head and neck tumorigenesis and can be detected by using microsatellite analysis. MI can also occur in early head and neck tumorigenesis Li et al., 1994; El-Naggar et al., 1995; Field, 1996) , and it may be signature in subsequent clonal cells (Mao et al., 1994) . If there are common clonal MOCP in a patient, certain genetic alterations that developed before clonal cells spreading should be identical in all clonally related MOCP. In contrast, if distinct patterns of genetic alterations are observed in MOCP, these lesions are likely to be clonally independent. It has been noticed that most existing studies reporting clonal relation of head and neck SPTs included only small numbers of cohorts, small numbers of SPTs from individual patients, small numbers of coexisting premalignant lesions, and mainly Caucasian patients. Therefore, the issue of clonality in SPTs should be further evaluated with a large number of cohort lesions and in various patient populations. In this study, we analysed 100 MOCP including 32 invasive tumors and 68 premalignant lesions from 26 Japanese patients to determine clonal association and potential pathways of the development of these multiple lesions.
Results
Clinical characteristics
Each of the 26 patients had 2 ± 17 MOCP (mean 3.85 lesions per patient) with various pathologic features. Lesions were synchronous or metachronous in distinct geographic areas of the oral cavity. There were 49 low grade precancerous lesion (PLs) (four hyperplasia, 28 mild dysplasia, and 17 moderate dysplasia), and 19 high grade PLs (nine severe dysplasia and 10 carcinoma in situ [CIS] ) and 32 invasive carcinomas. Fifteen patients presented with low-grade PLs as ®rst index lesions, and subsequently developed 24 MOCP (mean, 1.6 per patient) developed synchronously or metachronously from 6 months to 13 years after ®rst diagnosis. Seven patients had high-grade PLs as ®rst index lesions and 17 MOCP (mean, 2.4 per patient) developed at the same time or from 1 month to 7 years after ®rst diagnosis. The ®rst index lesions of four patients were (IC), and 33 MOCP (mean 8.3 per patient) subsequently developed in these patients synchronously in two patients and during 10 and 13 years follow-up care in two patients. In six patients multiple ICs (total 32 ICs) developed at anatomically distinct areas (mean, 6.3 per patient).
Frequencies of LOH
We analysed two polymorphic microsatellite markers for chromosomal locus of 3p14. In 78 (78%) of the 100 lesions from 21 (81%) of the 26 patients, at least one marker could be analysed for LOH. Among these informative lesions, 41 (53%) from 15 (71%) patients showed LOH. Using four microsatellite markers at 9p21, the informative rate was 96% from 26 (100%) patients. DNA from four lesions of four patients could not be ampli®ed by the informative markers. Sixty (63%) of 96 lesions from 16 (62%) patients showed LOH in at least in one of the four markers. Fifty-four (54%) lesions from 15 (58%) patients were informative for the TP53 marker located at 17p13 locus. Among the 54 lesions, 32 (59%) lesions from 15 patients showed LOH.
Frequencies of MI
MI was observed in 11 (11%) and 26 (26%) of the MOCP in at least one marker at 3p14 and 9p21, respectively. At the chromosomal locus 17p13, 13 (13%) of the MOCP showed MI.
MA and histopathological features
We studied the frequencies of LOH and MI in the three chromosomal loci analysed and the histopathological features of the MOCP. There was no signi®cant dierence in the frequencies of LOH at 3p14 and 17p13 in premalignant lesions or invasive lesions, although the frequencies of LOH tended to be higher in invasive lesions (Table 1) 
Clonal relationship of MOCP
The clonal relationships among the MOCP were determined according to the criteria described in the Table 2 . Lesions from 20 (77%) patients with median 52 months follow-up exhibited dierent alleotypes, suggesting their multiclonal origins (Table 2 and Figure 1 ) while Lesions from six (23%) patients with median 57 months follow-up showed evidence of clonal relationships (Figures 2 and 3) . Among 15 patients presented with a low-grade PL as their ®rst index lesion, three showed evidence of a clonal relationship in their MOCP (Table 2) .
In case 5, an identical novel microsatellite shift at marker D9S171 and a same pattern of LOH at marker TP53 were seen among the index lesion and two of three subsequent ICs. The index lesion was mild dysplasia in the upper right gingiva; two of three subsequent ICs were found on the right side of the hard palate and in the lower right gingiva 3 ± 4 years after the index lesion was diagnosed ( Figure 2a ).
Case 9 showed identical novel microsatellite shifts at both D3S1234 and D3S1481 in the index lesion, which was a mild dysplasia located on the left side of the hard palate and a dysplastic lesion developed 3 months later on the right side of the hard palate ( Figure 2b) .
Two of four lesions from case 24 disclosed an identical pattern of LOH at D3S1234 and microsatellite shift at D9S1747 (Figure 2c) . Similarly, one (Case 14) of the seven patients who presented with a high-grade PL as an index lesion showed an identical LOH pattern at D3S1234 and MI for TP53 in both the index CIS lesion, which was located in the upper right gingiva, and in one of three lesions that developed 6 weeks later in the right retromolar area (Figure 2d ). However, two other synchronous lesions of the upper right gingiva and the upper left gingiva showed dierent allelotypes compared with that of the index lesion ( Figure 2d ). Overall, in only four (18%) of 22 patients with noninvasive index lesions was there evidence of a clonal relationship.
Interestingly, in four patients whose index lesions were IC, 28 ICs and ®ve PLs developed later in the oral cavity. Although the patterns of MA in the lesions were complex, we were able to identify evidence of clonal relationships among 15 invasive tumors and one severely dysplastic lesion from two (50%) patients. In case 4, 14 MOCP developed in 11 years, including nine ICs. Lesions 2 and 5, which developed about 2 months apart, showed identical MI at both D3S1234 and TP53, and the same pattern of LOH at D3S1481, suggesting a common clonal origin of the two lesions. Although dierent from lesions 2 and 5, lesions 10 and 14 shared the same allelotype at four dierent markers (Figures 3a  and 4a) , suggesting a clonal relationship whose probability of occurrence is less than 0. (Figure 3b) . The third and seventh lesions showed an identical novel microsatellite alleles at the TP53 marker, while the tenth, eleventh and thirteenth lesions showed another indentical microsatellite shift at the marker (Figure 4b ), again suggesting common clonal origins. It is possible that the 17 lesions were the results of the clonal expansion of six independently developed malignant cells. The two lesions with severe dysplastic histology might be the result of section variations and in fact part of cancerous lesions because both lesions were diagnosed as invasive tumor in the original pathological examination.
Interestingly, the number of MOCP per patient is not signi®cantly associated with the pathological grades of the ®rst index lesions (P=0.08 by the Wilcoxon rank-sum test). (Table 3) . However, the patients who have clonal MOCP were identi®ed to develop more SPTs than the patients who have nonclonal MOCP (P=0.017 by the Wilcoxon ranksum test) (Table 3) .
Discussion
The oral cavity represents a ®eld wherein exposure to carcinogens may allow multiple preneoplastic lesions to develop in the area synchronously and metachronously. Clinicopathological observations indicate that oral preneoplastic lesions progress to invasive cancer (Silverman et al., 1984; Einhorn and Wersall, 1967) , and multiple invasive cancers can also occur in the compromised ®eld (Slaughter et al., 1953; Cianfriglia et al., 1999) . However, a recent ®nding that many oral SPTs share identical genetic alterations with their primary index tumors raises the possibility that oral epithelial cells may start to spread early in the tumorigenic process (Bedi et al., 1996; Scholes et al., 1998) . Analysing clonal genetic relationships among multiple PLs should provide an insight into the potential mechanism of how multiple oral lesions develop. To test clonal relationships among MOCP, we performed microsatellite analysis using selected markers that represent chromosomal loci altered early in oral tumorigenesis.
Chromosome 9p21 containing p16 tumor suppressor gene is frequently lost in HNSCC as well as oral preneoplastic lesions (Bishop et al., 1987; Van der Reit et al., 1994) . Chromosome 3p14 contains the tumor suppressor gene FHIT as well as a common fragile site, FRA3B (Ohta et al., 1996) . The region is frequently deleted in early tumorigenesis (Roz et al., 1996; Mao et al., 1996) , and the deletion is associated with exposure to cigarette smoke (Tseng et al., 1999) . Loss of chromosome 17p13 harboring p53 tumor suppressor gene, is also common in multistep head and neck tumorigenesis . In this study, we found LOH in 25 (44%) of 57, 30 (46%) of 65, and 20 (54%) of 37 informative PLs analysed at 3p14, 9p21, and 17p13, respectively. The data are similar to previous reports and support the notion that these genetic changes occur in early stages of oral carcinogenesis. The increased frequency of LOH in invasive tumors at the 9p21 locus suggests that the region, probably the p16 gene, is important in early malignant progression. These results indicate that the genetic changes occurred in the early stages of neoplastic progression in the Japanese patient population in our study.
To analyse clonality, MA as well as X chromosome inactivation patterns have been used as markers (Mao et al., 1994; Allen et al., 1992) . However, our recent data indicate that X chromosome inactivation analysis using PCR-based strategy may not be reliable due to the complicated methylation patterns of CpG sites in the androgen receptor gene commonly used in the assays (Jang and Mao, 2000) . Most of the previous reports concerning clonal relationships of SPTs included small numbers of cohorts, small numbers of SPTs from individual patients, small numbers of coexisting premalignant lesions, and mainly Caucasian study population. In this study, therefore, we focused on microsatellite analysis to determine clonal relationships of MOCP.
In our patient population, most PLs disclosed dierent allelotypes in the microsatellite analysis at the 3p, 9p, and 17p chromosomal loci, suggesting their multifocal origins (Table 2 and Figure 1 ). However, seven PLs from four patients exhibited evidence of clonal relationships (Figure 2 ), indicating the possibility of clonal spreading during the premalignant stage, although the chances of that are low. Recent reports of clonal analysis using spatial distribution of p53 mutation in PLs of Barrett's esophagus also provided evidence for multifocal carcinogenesis or mucosal spreading of clonal cells (Prevo et al., 1999) . However, it should be emphasized that the possibility of mucosal spreading of a monclonal cell population still cannot be excluded completely in some cases having distinct MA before the earliest genetic alteration conferring a growth advantage could be identi®ed.
On the other hand, we, like earlier investigators, found evidence of clonal relationships more frequent in the patients who presented with invasive cancer (Bedi et al., 1996; Scholes et al., 1998; Lydiatt et al., 1998) . Two of four patients who presented with invasive cancers showed 16 clonally related tumors among 31 MOCP (Figure 3) . Among 63 lesions from 22 patients with initial PLs, 14 (22%) were clonally related, while 16 (43%) of the 37 lesions from patients with initial ICs showed evidence of clonal relationships. Our data stress that multiple head and neck tumors could develop in two dierent pathways: ®eld cancerization or mucosal spreading of clonal cells. Although mucosal spread of genetically altered cells can occur in the early stages of tumorigenesis, most PLs may develop by ®eld cancerization with independent clonal origins. Cells from many invasive cancers may be replanted or migrate submucosally to remain in distinct geographic locations for years before growing into new tumors. Cases 4 and 22 highlight the complex co-eects of the two dierent pathways. Allelotyping of Case 4 suggests that the patient developed three dierent lineages of cancers (Figure 4a ): a group of cancers that lost the upper allele for D3S1234, D3S1481 and D9S1747, a group of cancers having loss of lower allele for D3S1234, D3S1481 and D9S1747, and another group of cancers that lost the upper allele for TP53. The allelotypes seen in case 22 suggest that more than ®ve dierent lineages of cancers developed during 14 years (Figure 4b) . Interestingly, each of 12 informative cases disclosed the loss of the lower allele for D9S162. The result suggests either early genetic change before the spread of transformed cells or allelespeci®c loss (Hung et al., 1995) .
For the eective management of SPTs, dierent strategies may be mandatory according to the development mechanism of the tumor. For example, to treat patients with multiple clonal SPTs, chemoprevention may be necessary in addition to eradicate existing tumors. In patients with a single clonal SPT the focus should be to eliminate micrometastases. However, most if not all patients with multiple clonally related tumors also have ®eld defects evidenced by the coexistence of independently developed lesions. Therefore, preventive strategies should probably apply to all of these patients.
In conclusion, we provide here molecular bases of clonal association among MOCP. The majority of MOCP arise from clonally independent cells aected by ®eld cancerization. However, the probability of mucosal spread of clonal malignant or premalignant cells may increase with malignant progression. Identi®cation of the additional early genetic alterations needed for neoplastic transformation and the genetic changes responsible for the early spread of transformed cells should be explored further.
Materials and methods
Patient selection
Twenty-six Japanese patients with MOCP who were treated at the Hokkaido University School of Dentistry between 1974 and 1996 were selected for this study. The criteria for the patient selection were the presence of MOCP located at geographically distinct areas; patients whose treatment was local resection of tumors or precancerous lesions and whose tissue samples were available; and availability of complete clinical information with accurate mapping of graphic mapping of MOCP. A total of 100 MOCP with various pathological stages, including 49 low grade PLs (hyperplasias or mild dysplasias), 19 high grade PLs (severe dysplasias or CIS), and 32 invasive squamous carcinomas were identi®ed from these patients.
Microdissection and DNA extraction
Formalin-®xed and paran embedded tissues were serially sectioned at 8-mm thickness and stained with hematoxyline and eosin. Histopathologic diagnoses were reviewed and con®rmed by a pathologist (SJ Jang). Squamous epithelial lesions were microdissected under a dissecting stereomicroscope. Stromal tissues were obtained simultaneously to use as normal controls. Dissected tissues were digested ®rst in 100 ml digestion buer containing 50 mM Tris-HCL (pH 8.0), 1% sodium dodecyl sulfate, and 0.5 mg/ml proteinase K at 428C for 24 h and for another 24 h with additional proteinase K. The digestion products were subjected to phenol-chloroform extraction twice and ethanol precipitation in the presence of glycogen (Boehringer-Mannheim, Indianapolis, IN, USA). The pellets were re-suspended in distilled water.
Microsatellite analysis
Seven polymorphic markers were obtained from Research Genetics (Huntsville, AL, USA) for analysing loci on chromosomes 3p14, 9p21, and 17p13, which are known as sites of early genetic changes in oral carcinogenesis. The markers were D3S1234 and D3S1481 at 3p14 at the locus of the puntative tumor suppressor gene FHIT (Ohta et al., 1996; Roz et al., 1996) , D9S171, D9S1747, RPS6, and D9S162 for 9p21 at the locus of tumor suppressor genes p16, p15, and p14 (Van der Kim et al., 1997) , and TP53 for 17p13 at the locus of the p53 tumor suppressor gene (Mao et al., 1998) . One of the primers for each marker was end-labeled with g-32 P-d-ATP (4500 Ci/mmole; ICN Biomedicals, Costa Mesa, CA, USA) and T4 DNA polynucleotide kinase (New England Biolabs, Beverly, MA, USA). Each PCR ampli®cation was performed in an 8-ml volume containing 200 mM dNTP, 1.5 mM MgCl 2 , 0.4 mM of PCR primers including 0.01 mM g-32 P-labeled primer, 0.5 u Taq DNA polymerase (GIBCO BRL, Gaitherberg, MD, USA), and genomic DNA compatible to at least 100 cells. The reactions were conducted for 40 cycles at 958C for 30 s, 54 to 598C for 60 s, and 708C for 60 s followed by a 5-min extansion at 708C in a thermal cycler (Hybaid; Omnigene, Woodbridge, NJ, USA) in 500-ml plastic tubes. Ampli®cation products were separated on a 7% polyacrylamide-ureaformamide gel for 2 ± 4 h and then exposed to X-ray ®lm for 12 ± 72 h. LOH was scored when signal intensity of one allele decreased 50% or more compared with that of corresponding normal controls. MI was de®ned as appearance of one or more new alleles in tumor DNA as compared with normal counterparts. The results were interpreted visually by two independent observers (SJ Jang and L Mao).
Determination of clonal relationship
Lesions were judged to be clonally related if they shared an identical novel microsatellite shift and/or the same allelotypes in at least four microsatellite makers at two dierent chromosomal loci. If MOCP developed independently, the probability of exhibiting the same allelotypes in two dierent lesions at two dierent markers by chance could be theoretically calculated using the formula: P (probability)=R 2 6(L/2) 2 . (R and L represent probabilities of retention and LOH, respectively). The probability of retention and the probability of LOH could be calculated by an experimental data, i.e. R=number of instances of retinoid/number of informative cases and L=number of instances of LOH/number of informative cases. When more than two lesions are compared, the presence of identical changes in all the lesions increases the likelihood that they are clonally related. It should be noted that the criteria are relative because they may underestimate or overestimate clonally associated MOCP. However, if identical MI is also observed in dierent lesions, it becomes almost certain that they are of the same clonal origin. Chi-square, Wilcoxon rank-sum, or Fisher's exact tests were used to determine the dierence in frequencies. All tests were two-sided. A P50.05 was considered statistically signi®cant.
